Abstract
Viral proteins evolve to benefit the interaction with host proteins during the infection and replication processes. A comprehensive understanding of virus interactome with host proteins may thus lead to the identification of molecular targets for infection inhibition. We present a procedure for isolating and identifying the dengue virus interactome with human plasma proteins. It comprises the fractionation of human plasma by anion exchange chromatography, followed by affinity purification and mass spectrometry identification of the captured proteins. This procedure was applied to the characterization of the interactions of the four serotypes of dengue virus with human plasma proteins, mediated by the domain III of the envelope protein of the virus. The resulting interactome comprises 62 proteins, six of which were validated as new direct interactions of the virus with its human host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
de Chassey B, Meyniel-Schicklin L, Vonderscher J et al (2014) Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med 6(11):115
Epperson ML, Lee CA, Fremont DH (2012) Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev 250(1):199–215
Agrawal P, Nawadkar R, Ojha H et al (2017) Complement evasion strategies of viruses: an overview. Front Microbiol 9:1117. https://doi.org/10.3389/fmicb.2017.01117
Green AM, Beatty PR, Hadjilaou A et al (2014) Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol 426(6):1148–1160
Meertens L, Carnec X, Lecoin MP et al (2012) The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12(4):544–557
Li Y, Kakinami C, Li Q et al (2013) Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI. PLoS One 8(7):e70390
Bhattacharyya S, Zagórska A, Lew ED et al (2013) Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe 14(2):136–147
Modhiran N, Watterson D, Muller DA et al (2015) Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med 7(304):304ra142
Beatty PR, Puerta-Guardo H, Killingbeck SS et al (2015) Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med 7(304):304ra141
Puerta-Guardo H, Glasner DR, Harris E (2016) Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog 12:e1005738. https://doi.org/10.1371/journal.ppat.1005738
Gordon DE, Jang GM, Bouhaddou M et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459. https://doi.org/10.1038/s41586-020-2286-9
Amemiya T, Gromiha MM, Horimoto K et al (2019) Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses. Sci Rep 9(1):523
Bhattacharjee S (2015) Recent advances in host–virus interactomics during entry and infection. Virus Adapt Treat 7:57
Chiu M-W, Shih H-M, Yang T-H et al (2007) The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). J Biomed Sci 14(3):429–444
Folly BB, Weffort-Santos AM, Fathman CG et al (2011) Dengue-2 structural proteins associate with human proteins to produce a coagulation and innate immune response biased interactome. BMC Infect Dis 11(1):34
Jitoboam K, Phaonakrop N, Libsittikul S et al (2016) Actin interacts with dengue virus 2 and 4 envelope proteins. PLoS One 11(3):e0151951
Khadka S, Vangeloff AD, Zhang C et al (2011) A physical interaction network of dengue virus and human proteins. Mol Cell Proteom 10:M111.012187. https://doi.org/10.1074/mcp.M111.012187
Limjindaporn T, Wongwiwat W, Noisakran S et al (2009) Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production. Biochem Biophys Res Commun 379(2):196–200
Mairiang D, Zhang H, Sodja A et al (2013) Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito. PLoS One 8(1):e53535
Lai J-H, Lin Y-L, Hsieh S-L (2017) Pharmacological intervention for dengue virus infection. Biochem Pharmacol 129:14–25
Nguyen NM, Tran CNB, Phung LK et al (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207(9):1442–1450
Low JG, Sung C, Wijaya L et al (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14(8):706–715
Luck K, Sheynkman GM, Zhang I et al (2017) Proteome-scale human interactomics. Trends Biochem Sci 42(5):342–354
Ivanov AS, Zgoda VG, Archakov AI (2011) Technologies of protein interactomics: a review. Russ J Bioorganic Chem 37(1):4–16
Guzman MG, Harris E (2015) Dengue. Lancet 385(9966):453–465
Rico-Hesse R (2010) Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol 338:45–55
Yung C-F, Lee K-S, Thein T-L et al (2015) Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, Singapore. Am J Trop Med Hyg 92(5):999–1005
Fried JR, Gibbons RV, Kalayanarooj S et al (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4:e617. https://doi.org/10.1371/journal.pntd.0000617
Vicente CR, Herbinger K-H, Fröschl G et al (2016) Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitória, Brazil. BMC Infect Dis 16(1):320
Balmaseda A, Hammond SN, Pérez L et al (2006) Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74(3):449–456
Khan AM, Miotto O, Nascimento EJM et al (2008) Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis 2:e272. https://doi.org/10.1371/journal.pntd.0000272
Chen H-R, Lai Y-C, Yeh T-M (2018) Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate. J Biomed Sci 25(1):58
Noisakran S, Onlamoon N, Songprakhon P et al (2010) Cells in dengue virus infection in vivo. Adv Virol 2010:1–15
Li H (2015) Radiology of infectious diseases, vol 1. Springer, New York, NY
Vaughn DW, Green S, Kalayanarooj S et al (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181(1):2–9
Tricou V, Minh NN, Farrar J et al (2011) Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl Trop Dis 5(9):e1309
Moi ML, Lim C-K, Takasaki T et al (2010) Involvement of the Fc receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol 91(1):103–111
Huerta V, Toledo P, Fleitas N et al (2014) Receptor-activated human α2-macroglobulin interacts with the envelope protein of dengue virus and protects virions from temperature-induced inactivation through multivalent binding. J Gen Virol 95(Pt 12):2668–2676
Ramos Y, Huerta V, Martín D et al (2019) An “on-matrix” digestion procedure for AP-MS experiments dissects the interplay between complex-conserved and serotype-specific reactivities in Dengue virus-human plasma interactome. J Proteome 193:71–84
Hortin GL, Sviridov D, Anderson NL (2008) High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin Chem 54(10):1608–1616
Omenn GS, States DJ, Adamski M et al (2005) Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5(13):3226–3245
Gbormittah FO, Hincapie M, Hancock WS (2014) Development of an improved fractionation of the human plasma proteome by a combination of abundant proteins depletion and multi-lectin affinity chromatography. Bioanalysis 6(19):2537–2548
Wang M, Herrmann CJ, Simonovic M et al (2015) Version 4.0 of PaxDb: protein abundance data, integrated across model organisms, tissues, and cell-lines. Proteomics 15(18):3163–3168
Pundir S, Martin MJ, O’Donovan C (2017) UniProt protein knowledgebase. Methods Mol Biol 1558:41–55
Peralta R et al. (2020) Hypoalbuminemia: background, pathophysiology, etiology
Danforth CM, Orfeo T, Everse SJ et al (2012) Defining the boundaries of normal thrombin generation: investigations into hemostasis. PLoS One 7:e30385. https://doi.org/10.1371/journal.pone.0030385
Huerta V, Ramos Y, Yero A et al (2016) Dataset on protein composition of a human plasma sub-proteome able to modulate the Dengue 2 virus infection in Huh 7.5 cells. Data Brief 6:352–358
Huerta V, Ramos Y, Yero A et al (2016) Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteins. J Proteome 131:205–213
Miteva YV, Budayeva HG, Cristea IM (2013) Proteomics-based methods for discovery, quantification, and validation of protein–protein interactions. Anal Chem 85(2):749–768
Han X, Aslanian A, Yates JR (2008) Mass spectrometry for proteomics. Curr Opin Chem Biol 12(5):483–490
Meysman P, Titeca K, Eyckerman S et al (2017) Protein complex analysis: from raw protein lists to protein interaction networks. Mass Spectrom Rev 36(5):600–614
Gomez Y, Gallien S, Huerta V et al (2014) Characterization of protein complexes using targeted proteomics. Curr Top Med Chem 14(3):344–350
Pardo M, Choudhary JS (2012) Assignment of protein interactions from affinity purification/mass spectrometry data. J Proteome Res 11(3):1462–1474
Trinkle-Mulcahy L, Boulon S, Lam YW et al (2008) Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol 183(2):223–239
Ramos Y, Huerta V, Martín D et al (2017) An “on-matrix” digestion procedure for AP-MS experiments dissects the interplay between complex-conserved and serotype-specific reactivities in Dengue virus-human plasma interactome. J Proteome 193:71. https://doi.org/10.1016/j.jprot.2017.07.004
Gillette MA, Carr SA (2013) Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods 10(1):28–34
Carvalho PC, Junqueira M, Valente RH et al (2008) Caititu: a tool to graphically represent peptide sequence coverage and domain distribution. J Proteome 71(4):486–489
Finn RD, Coggill P, Eberhardt RY et al (2016) The Pfam protein families database: towards a more sustainable future. Nucleic Acids Res 44(D1):D279–D285
Douradinha B, McBurney SP, Soares de Melo KM et al (2014) C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. Virus Res 179:231–234
MacLean B, Tomazela DM, Shulman N et al (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26(7):966–968
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Huerta, V., Ramos, Y. (2022). Isolation and Identification of Dengue Virus Interactome with Human Plasma Proteins by Affinity Purification-Mass Spectrometry. In: Mohana-Borges, R. (eds) Dengue Virus. Methods in Molecular Biology, vol 2409. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1879-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1879-0_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1878-3
Online ISBN: 978-1-0716-1879-0
eBook Packages: Springer Protocols